298 automobile factories operating across Europe, new data shows

05.27.2020

298 automobile assembly and engine production plants operate in Europe today, according to freshly-updated data from the European Automobile Manufacturers’ Association (ACEA). Cars, vans, trucks, buses and engines are manufactured at these factories, 196 of which are situated within the European Union (EU27).

ACEA is publishing this data in the form of an interactive map which shows that 142 plants in Europe produce passenger cars, 38 make light commercial vehicles, 58 build heavy-duty vehicles, 58 produce buses, and 71 make engines. ACEA’s 16 member companies are active in 21 European countries.

«This data shows the sheer scale of our industry’s manufacturing footprint, spanning right across the European continent,» said Eric-Mark Huitema, ACEA’s Director General. «A successful re‐launch of the auto industry post-coronavirus will clearly be vital to Europe’s wider economic recovery.»

Since mid-March, the auto industry has been severely impacted by the COVID-19 crisis, with plants being shuttered for 29 working days on average to date. EU-wide production losses as a result of these factory shutdowns total over 2.3 million vehicles so far. Although a number of factories are slowly re-starting production, they are still operating well below their pre-lockdown capacity.

Eric-Mark Huitema: «If we are to return to full-scale production again, automobile manufacturers and suppliers must get their plants up and running in a quick and synchronised manner. That is why we are calling on the EU to support a coordinated re-start of activities and investments right along the supply chain. Measures will also need to be taken to stimulate demand, given that sales have crashed to an all-time low in many key markets.»

Analytics on topic
Article
02.03.2020
Transport: increasing oil consumption and greenhouse gas emissions hamper EU progress towards environment and climate objectives
Mobility plays a key role in the EU economy. However, the EU transport sector still relies heavily on fossil fuels and is responsible for one quarter of Europe’s greenhouse gas (GHG) emissions — a share that keeps growing. In addition, the sector is a significant source of air pollution despite significant progress achieved since 1990, especially of particulate matter (PM) and nitrogen dioxide (NO2), as well as the main source of environmental noise in Europe. Current efforts to limit the sector’s environmental and climate impacts in Europe are not sufficient to meet the EU’s long-term climate and environmental policy objectives.
Source: European Environment Agency
Report
06.20.2019
Report
06.20.2019
The Europe Pharmaceutical Industry in Figures
The pharmaceutical industry is a key partner in Europe’s fight against disease, developing new treatments and cures for patients across Europe. It is imperative that Europe remains a competitive destination for medical research and development by maintaining, sustaining and developing a predictable, robust regulatory and innovation-supportive incentives environment.
Source: European Federation of Pharmaceutical Industries and Associations